Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Aarti Drugs
Aarti Drugs
BSE: 524348NSE: AARTIDRUGSISIN: INE767A01016

10th-Oct-2019 20:26Source: BSE

Aarti Drugs - Statement Of Investor Complaints For The Quarter Ended September 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- Rushikesh Deole
Designation :- Company Secretary and Compliance Officer

Board Meeting (Aarti Drugs)

Meeting Date

Remark

2019-10-23

Audited Results

Sections
Follow us on
Available On
PCI DSS Compliant